Under the terms of a new agreement, Almirall will use the WuXiBody™ platform to develop bispecific antibodies for dermatological diseases. WuXi Biologics will receive an upfront payment as well as development, regulatory and commercial milestone payments for each bispecific antibody generated from this platform, and will also be entitled to royalties based on global sales generated by these projects. No matter how sensitive your molecule may be, Yourway is able to store a range of biopharmaceuticals. We offer storage within hours or even minutes of its destination, everywhere you do business.